Quest Diagnostics Investments Incorporated
Records under this name other than the patents Quest Diagnostics Investments Incorporated holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 409 patents it holds.
Back to Quest Diagnostics Investments Incorporated
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,137,410 | Prognostic Assays for Maintenance Hemodialysis Patients Held by another company In force · Low confidence | In force | Low confidence | |
| US 9,651,556 | Aptamers and diagnostic methods for detecting the EGF receptor Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,467,098 | Methylated Markers for Colorectal Cancer Held by another company In force · High confidence | In force | High confidence | |
| US D1,092,772 | Plunger Cap for Sampling Apparatus Held by another company In force · High confidence | In force | High confidence | |
| US 11,802,317 | Kits for Detecting Mycobacterium Avium/Intracellulare Nucleic Acid Term ended Ended no later than Aug 22, 2026 · Low confidence | Term ended | Ended no later than Aug 22, 2026 | Low confidence |
| US 7,838,646 | Cystic fibrosis transmembrane conductance regulator gene mutations Term ended Term ended Aug 18, 2026 · USPTO record | Term ended | Term ended Aug 18, 2026 | USPTO record |
| US 9,863,000 | Cystic fibrosis transmembrane conductance regulator gene mutations Term ended Ended no later than Aug 18, 2026 · USPTO record | Term ended | Ended no later than Aug 18, 2026 | USPTO record |
| US 10,655,179 | Cystic fibrosis transmembrane conductance regulator gene mutations Term ended Term ended Aug 18, 2026 · USPTO record | Term ended | Term ended Aug 18, 2026 | USPTO record |
| US 10,876,175 | Kits for detecting Mycobacterium avium/intracellulare nucleic acid Term ended Term ended Jul 22, 2026 · USPTO record | Term ended | Term ended Jul 22, 2026 | USPTO record |
| US 8,114,613 | Oxidized APOA1 determination by mass spectrometry Term ended Term ended Jul 18, 2026 · USPTO record | Term ended | Term ended Jul 18, 2026 | USPTO record |